uk 21 has been researched along with glycine in 5 studies
*Glycine: A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. [MeSH]
*Glycine: A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. [MeSH]
Studies (uk 21) | Trials (uk 21) | Recent Studies (post-2010) (uk 21) | Studies (glycine) | Trials (glycine) | Recent Studies (post-2010) (glycine) |
---|---|---|---|---|---|
5 | 0 | 0 | 35,163 | 756 | 8,415 |
Protein | Taxonomy | uk 21 (IC50) | glycine (IC50) |
---|---|---|---|
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 1.4852 | |
Sodium- and chloride-dependent glycine transporter 1 | Homo sapiens (human) | 106 | |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.3253 | |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.3253 | |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.3253 | |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.3253 | |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.3253 | |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.3253 | |
Sodium- and chloride-dependent glycine transporter 2 | Homo sapiens (human) | 128 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kato, T; Kitaichi, K; Koda, A; Mori, H; Sakamoto, O | 1 |
Kaku, Y; Kita, J; Koda, A; Maeda, D; Mori, H; Nagai, H; Nakayama, K | 1 |
Kitaichi, K; Koda, A; Mori, H; Sakamoto, O | 1 |
Abe, K; Hanafi, M; Shibata, K; Tanaka, T; Taniguchi, M; Ueki, M | 1 |
Ishida, R; Ito, S; Koda, A; Mori, H; Nagai, H; Nakayama, K | 1 |
5 other study(ies) available for uk 21 and glycine
Article | Year |
---|---|
Antitumor activity of two novel low immunosuppressive fluoropyrimidines UK-21 and UK-25.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Body Weight; Fluorouracil; Glycine; Leukemia L1210; Leukemia P388; Lung Neoplasms; Methylcholanthrene; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Organ Size; Sarcoma 180; Spleen; Tegafur; Thymus Gland; Uridine | 1992 |
Novel lowly immunosuppressive antitumor fluorouridine derivative, UK-21: antitumor activity and effect on humoral immune response in mice.
Topics: Analysis of Variance; Animals; Antibody Formation; Antineoplastic Agents; Carcinoma; Female; Glycine; Immunosuppressive Agents; Leukemia, Experimental; Lung Neoplasms; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Uridine | 1994 |
Novel low immunosuppressive derivatives of the antitumor drug fluoropyrimidine, UK-21 and UK-25: effect on delayed type hypersensitivity and tumor immunity.
Topics: Animals; Antineoplastic Agents; Erythrocytes; Female; Fluorouracil; Glycine; Hypersensitivity, Delayed; Immunity; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Sheep; Spleen; Uridine | 1993 |
UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. I. Fermentation, isolation, and biological properties.
Topics: Animals; Antibiotics, Antineoplastic; Antifungal Agents; Cell Division; Fermentation; Glycine; Humans; Lactones; Mice; Microbial Sensitivity Tests; Oxygen Consumption; Pyridines; Saccharomyces cerevisiae; Streptomyces; Tumor Cells, Cultured; Uridine | 1996 |
Irreversible cytotoxic effect of a novel lowly immunosuppressive antitumor fluorouridine derivative, UK-21.
Topics: Antimetabolites, Antineoplastic; Cell Cycle; Cell Survival; Flow Cytometry; Floxuridine; Fluorouracil; Glycine; Humans; Immunosuppressive Agents; KB Cells; Neoplastic Stem Cells; Thymidine; Uridine | 1997 |